NASDAQ:PYXS | Cash Flow Statement | Pyxis Oncology, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$25.35M
2026-03-31-$23.27M$459,000.00-$26M$16.37M-$25,000.00
2025-12-31-$18.11M$2.9M-$10.43M$0.00$16.26M$669,000.00
2025-09-30-$22M
2025-06-30-$18.35M
2025-03-31-$21.16M$552,000.00-$22.54M$15.82M$0.00
2024-12-31-$35.57M$550,000.00-$19.29M$0.00$26.66M$50,000.00
2024-09-30-$21.2M
2024-06-30-$17.3M
2024-03-31-$3.26M$1.12M-$20.71M$237,000.00-$18.5M$57.51M
2023-12-31-$15.6M$690,000.00-$15.25M$0.00$10.23M-$25,000.00
2023-09-30-$23.05M
2023-06-30-$15.9M
2023-03-31-$19.24M$190,000.00-$26.84M$4.41M-$99.39M
2022-12-31-$36.1M$192,000.00-$17.39M$1.86M-$1.86M$0.00
2022-09-30-$27.67M
2022-06-30-$25.56M
2022-03-31-$31.38M$158,000.00-$27.68M$146,000.00-$146,000.00$176,000.00
2021-12-31-$16.83M$158,000.00-$12.17M$0.00$0.00$154.9M
2021-09-30-$14.18M
2021-06-30-$8.15M
2021-03-31-$36.83M$113,000.00-$18.73M$169,000.00-$219,000.00$151.53M
2020-12-31-$4.58M$170,000.00-$3.17M$0.00$0.00$1,000.00
2020-09-30-$3.19M
2020-06-30-$3.1M
2020-03-31-$1.96M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$79.62M$4.51M-$63.5M$9,000.00$58.86M$594,000.00
2024-12-31-$77.33M$2.98M-$57.67M$237,000.00$8.16M$59.33M
2023-12-31-$73.79M$1.93M-$70.71M$6.73M-$104.85M$5.93M
2022-12-31-$120.72M$709,000.00-$89.34M$6.4M-$6.4M$183,000.00
2021-12-31-$75.98M$647,000.00-$35.33M$540,000.00-$590,000.00$304.04M
2020-12-31-$12.83M$469,000.00-$10.08M$1.48M-$1.48M$35,000.00